Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin before thrombolysis in STEMI
IRCT20111206008307N34Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of metformin in myocardial infarction (MI) and coronary arteriosclerosis (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Cardiac troponin I level. Started Jan 2020; status: completed.
02
Drugs
metformin
03
Conditions
myocardial infarction (MI)coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20111206008307N34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20111206008307N34.